BWG Global upgraded its view of Corteva (CTVA) to Positive from Mixed, citing checks pointing to an improved sales outlook.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTVA:
- Corteva price target raised to $70 from $68 at Citi
- Corteva, Hexagon Bio enter multi-million-dollar crop protection joint venture
- Corteva’s Growth Potential Bolstered by Strategic Collaborations and Legal Developments
- Corteva assumed with an Overweight at Wells Fargo
- Corteva price target raised to $76 from $75 at Oppenheimer